Chatbot-assisted therapy for patients with methamphetamine use disorder: a preliminary randomized controlled trial
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Methamphetamine (MA) use disorder is associated with a large public health burden. Despite the therapeutic effects of psychosocial interventions based on current evidence, finding an approach to retain patients in treatment remains a real-world challenge. The rapid development of mobile health (mHealth) systems suggests the potential to provide real-time personalized care at any time and from any location, minimize barriers to treatment, maximize use, and promote the dissemination of accessible therapeutic tools in at-risk populations. Our study aimed to investigate the feasibility and effectiveness of chatbots for the treatment of MA use disorder. Method: The inclusion criteria were (a) a diagnosis of MA use disorder as defined by the DSM-5, (b) age between 18 and 65 years, (c) no acute exacerbation of severe mental illness during the initial assessment, such as schizophrenia or bipolar I disorder, (d) willingness to participate in standard outpatient treatment for ≥ 6 months, and (e) an Android phone. Participants were randomly allocated to either a chatbot-assisted therapy via smartphone (CAT) group or a control group following simple randomization procedures (computerized random numbers) without blinding. All participants were followed up for 6 months. Treatment retention and monthly urine test results were analyzed as outcome measures. Participants' satisfaction with CAT was also assessed. Results: In total, 50 and 49 participants were allocated to the CAT and control groups, respectively. There were no significant differences in retention time between the two treatment groups (df = 1, p = 0.099). The CAT group had fewer MA-positive urine samples than the control group (19.5% vs. 29.6%, F = 9.116, p = 0.003). The proportion of MA-positive urine samples was positively correlated with the frequency of MA use (r = 0.323, p = 0.001), severity of MA use disorder (r = 0.364, p < 0.001), and polysubstance use (r = 0.212, p = 0.035), and negatively correlated with readiness to change (r = −0.330, p = 0.001). Totally 55 participants completed the study at the 6-month follow-up and 60% reported relative satisfaction. Conclusion: Participants in this study had favorable acceptance and generally positive outcomes, which indicates that chatbot is feasible for treating people who use MA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017) · JMIR Mental Health · doi:10.2196/mental.7785 · Cited by 2,730
Mobile app rating scale: a new tool for assessing the quality of health mobile apps
Stoyanov, S. R., Hides, L., Kavanagh, D. J., Zelenko, O., Tjondronegoro, D., & Mani, M. (2015) · JMIR mHealth and uHealth · doi:10.2196/mhealth.3422 · Cited by 2,233
Behavior change interventions delivered by mobile telephone short message service
Fjeldsoe, B. S., Marshall, A. L., & Miller, Y. D. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.09.040 · Cited by 1,213 · cited 1×
“Delivering interventions through mHealth offers several benefits, including continuous therapeutic support regardless of time and location, low barriers to access due to geographic isolation, and convenient dissemination to at-risk populations (31, 32).”
BackgroundThe impact of mHealth interventions: systematic review of systematic reviews
Marcolino, M. S., Oliveira, J. A. Q., D'Agostino, M., Ribeiro, A. L., Alkmim, M. B. M., & Novillo-Ortiz, D. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8873 · Cited by 1,163
Chatbots and Conversational Agents in Mental Health: A Review of the Psychiatric Landscape
Vaidyam, A. N., Wisniewski, H., Halamka, J. D., Kashavan, M. S., & Torous, J. B. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719828977 · Cited by 1,048 · cited 2×
“The use of chatbots in psychotherapy offers several benefits, such as increased accessibility, convenience, and affordability (41, 42).”
BackgroundIt's only a computer: virtual humans increase willingness to disclose
Lucas, G. M., Gratch, J., King, A., & Morency, L.-P. (2014) · Computers in Human Behavior · doi:10.1016/j.chb.2014.04.043 · Cited by 977 · cited 1×
“also found that a chatbot was effective in eliciting sensitive information and demonstrating higher symptom disclosure, as well as decreasing fear of self-disclosure (44).”
BackgroundMindfulness-Based Relapse Prevention for Substance Use Disorders: A Pilot Efficacy Trial
Bowen, S., Chawla, N., Collins, S. E., Witkiewitz, K., Hsu, S., Grow, J., Clifasefi, S., Garner, M., Douglass, A., Larimer, M. E., et al. (2009) · Substance Abuse · doi:10.1080/08897070903250084 · Cited by 715
Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., Carroll, H. A., Harrop, E., Collins, S. E., Lustyk, M. K., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4546 · Cited by 701
Mobile phone messaging for facilitating self-management of long-term illnesses
de Jongh, T., Gurol-Urganci, I., Vodopivec-Jamsek, V., Car, J., & Atun, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007459.pub2 · Cited by 599
Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.09.006 · Cited by 561
Cited by
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review
Laymouna, M., Ma, Y., Lessard, D., Schuster, T., Engler, K., & Lebouché, B. (2024) · Journal of Medical Internet Research · doi:10.2196/56930 · Cited by 305
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review (Preprint)
Laymouna, M., Ma, Y., Lessard, D., Schuster, T., Engler, K., & Lebouché, B. (2024) · doi:10.2196/preprints.56930 · Cited by 302
Hua, Y., Siddals, S., Ma, Z., Galatzer‐Levy, I., Xia, W., Hau, C., Na, H., Flathers, M., Linardon, J., Ayubcha, C., et al. (2025) · World Psychiatry · doi:10.1002/wps.21352 · Cited by 117
Feng, X., Tian, L., Ho, G. W. K., Yorke, J., & Hui, V. (2025) · Journal of Medical Internet Research · doi:10.2196/79850 · Cited by 51
Amer, M., Gittins, R., Millana, A. M., Scheibein, F., Ferri, M., Tofighi, B., Sullivan, F., Handley, M., Ghosh, M., Baldacchino, A., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/58723 · Cited by 5
Metadata
- Authors
- Chun-Hung, L., Guan-Hsiung, L., Wu-Chuan, Y., & Yu-Hsin, L.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-07-07
- Volume
- 14
- Pages
- 1159399-1159399
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W4383552383
- Cited by
- 21
- References
- 28
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chatbot-assisted therapy for patients with methamphetamine use disorder: a preliminary randomized controlled trial. https://app.cochat.ai/papers/10.3389/fpsyt.2023.1159399
- The paper
- Chun-Hung, L., Guan-Hsiung, L., Wu-Chuan, Y., & Yu-Hsin, L. (2023). Chatbot-assisted therapy for patients with methamphetamine use disorder: a preliminary randomized controlled trial. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1159399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.